LMAT Relative Valuation
LMAT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LMAT is overvalued; if below, it's undervalued.
Historical Valuation
LeMaitre Vascular Inc (LMAT) is now in the Fair zone, suggesting that its current forward PE ratio of 33.21 is considered Fairly compared with the five-year average of 39.99. The fair price of LeMaitre Vascular Inc (LMAT) is between 82.88 to 104.01 according to relative valuation methord.
Relative Value
Fair Zone
82.88-104.01
Current Price：85.70
Fair
33.21
PE
1Y
3Y
5Y
Trailing
Forward
21.47
EV/EBITDA
LeMaitre Vascular Inc. (LMAT) has a current EV/EBITDA of 21.47. The 5-year average EV/EBITDA is 23.89. The thresholds are as follows: Strongly Undervalued below 16.70, Undervalued between 16.70 and 20.30, Fairly Valued between 27.49 and 20.30, Overvalued between 27.49 and 31.09, and Strongly Overvalued above 31.09. The current Forward EV/EBITDA of 21.47 falls within the Historic Trend Line -Fairly Valued range.
24.90
EV/EBIT
LeMaitre Vascular Inc. (LMAT) has a current EV/EBIT of 24.90. The 5-year average EV/EBIT is 30.36. The thresholds are as follows: Strongly Undervalued below 21.74, Undervalued between 21.74 and 26.05, Fairly Valued between 34.67 and 26.05, Overvalued between 34.67 and 38.99, and Strongly Overvalued above 38.99. The current Forward EV/EBIT of 24.90 falls within the Undervalued range.
7.28
PS
LeMaitre Vascular Inc. (LMAT) has a current PS of 7.28. The 5-year average PS is 6.99. The thresholds are as follows: Strongly Undervalued below 4.70, Undervalued between 4.70 and 5.84, Fairly Valued between 8.14 and 5.84, Overvalued between 8.14 and 9.28, and Strongly Overvalued above 9.28. The current Forward PS of 7.28 falls within the Historic Trend Line -Fairly Valued range.
31.39
P/OCF
LeMaitre Vascular Inc. (LMAT) has a current P/OCF of 31.39. The 5-year average P/OCF is 41.52. The thresholds are as follows: Strongly Undervalued below 14.38, Undervalued between 14.38 and 27.95, Fairly Valued between 55.09 and 27.95, Overvalued between 55.09 and 68.66, and Strongly Overvalued above 68.66. The current Forward P/OCF of 31.39 falls within the Historic Trend Line -Fairly Valued range.
29.01
P/FCF
LeMaitre Vascular Inc. (LMAT) has a current P/FCF of 29.01. The 5-year average P/FCF is 36.72. The thresholds are as follows: Strongly Undervalued below 27.88, Undervalued between 27.88 and 32.30, Fairly Valued between 41.13 and 32.30, Overvalued between 41.13 and 45.55, and Strongly Overvalued above 45.55. The current Forward P/FCF of 29.01 falls within the Undervalued range.
LeMaitre Vascular Inc (LMAT) has a current Price-to-Book (P/B) ratio of 5.13. Compared to its 3-year average P/B ratio of 5.21 , the current P/B ratio is approximately -1.46% higher. Relative to its 5-year average P/B ratio of 5.05, the current P/B ratio is about 1.52% higher. LeMaitre Vascular Inc (LMAT) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.95%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.41% , the current FCF yield is about -100.00% lower.
5.13
P/B
Median3y
5.21
Median5y
5.05
3.44
FCF Yield
Median3y
1.95
Median5y
2.41
Competitors Valuation Multiple
The average P/S ratio for LMAT's competitors is , providing a benchmark for relative valuation. LeMaitre Vascular Inc Corp (LMAT) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 11.36%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of LMAT decreased by 6.99% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 20.32 to 28.44.
The secondary factor is the Revenue Growth, contributed 11.36%to the performance.
Overall, the performance of LMAT in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is LeMaitre Vascular Inc (LMAT) currently overvalued or undervalued?
What is LeMaitre Vascular Inc (LMAT) fair value?
How does LMAT's valuation metrics compare to the industry average?
What is the current P/B ratio for LeMaitre Vascular Inc (LMAT) as of Dec 05 2025?
What is the current FCF Yield for LeMaitre Vascular Inc (LMAT) as of Dec 05 2025?
What is the current Forward P/E ratio for LeMaitre Vascular Inc (LMAT) as of Dec 05 2025?